Surrozen Inc

Biotech Stocks Healthcare Stocks

$25.62

+3.98 (+18.39%)

As of Aug 15, 2:10 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target -69.0% upside

Low Target $5.53

Average Target $7.94

High Target $9.87

Current Price $25.62

Current
$25.62

Target
$7.94

$5.53 $7.94 avg $9.87

Scenario Analysis

Bear Case

$5.53

-78.4%

Low target

Base Case

$7.94

-69.0%

Avg target

Bull Case

$9.87

+-61.5%

High target

Risk/Reward

0.8x

Unfavorable

Price in Context

52-Week High

$35.00

-26.8% from high

52-Week Low

$10.06

+154.7% from low

Target vs 52W High

$7.94

-77.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%